Now Accepting Nominations
2023 Harrington Prize
Scientific Symposium Celebrates a Decade of Drug Development
Novel Oral SIK Inhibitors for Musculoskeletal Diseases Licensed to Radius Health
Chiesi acquires potential treatment for PAH
Researchers Identify a New Treatment for Metabolic Syndrome
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19
Looking at Alzheimer’s Differently
A Novel Small Molecule with a Broad Range of Therapeutic Applications for Cancer Treatment
A Breakthrough Topical Treatment for Skin Cancer
Harrington Discovery Institute Brings Families Hope
Advancing Novel Treatments for Rare Neurological Diseases
Celebrating 10 Years of Discovery
Oxford-Harrington Rare Disease Centre Hosts Live Webinar for Rare Disease Day